In-Orbit pharma Opportunity in supplying equipment and services for in-orbit pharmaceutical processing and microgravity R&D, including autonomous spacecraft and reentry systems, to support Varda’s expansion into space-based medicine manufacturing.

Autonomous Manufacturing Sales potential around autonomous free-flying spacecraft and microgravity production capabilities, offering hardware, software, and integration services that enable scalable in-space manufacturing for pharma and advanced materials.

Strategic Partnerships Strong collaboration trajectory with United Therapeutics and other pharma players signals demand for contract manufacturing, process development, and space-enabled clinical/product pipelines.

Space Infrastructure Upsell opportunities in space infrastructure stack beyond capsules, including re-entry capsules, in-orbit processing modules, data analytics, and telemetry systems leveraging Varda’s tech ecosystem (MongoDB, Splunk, Cisco, Arm).

Scale and Funding Financials and growth trajectory (hundreds of millions in revenue potential, substantial funding) indicate appetite for long-term strategic vendors of space-grade components, manufacturing platforms, and lifecycle services.